Skip to main content
. 2021 May 28;93(9):5568–5573. doi: 10.1002/jmv.27099

Table 3.

Multivariate analysis of suPAR and KIM‐1 levels in patients with moderate and severe COVID‐19

Variable Moderate (mean ± SD) (n = 62) Severe (mean ± SD) (n = 40) Type III sum of squares F p Wilk's λ
suPAR (ng/ml) 8.4 ± 4.2 5.5 ± 3.1 198.942 13.637 0.001 0.219
KIM‐1 (pg/ml) 84.5 ± 62.3 134.9 ± 66.5 61989.318 15.151 0.001

Abbreviations: COVID‐19, coronavirus disease 2019; KIM‐1, kidney injury molecule‐1; suPAR, soluble urokinase plasminogen activator receptor.